Does Diazepam Cause Euphoria?
Yes, diazepam can cause euphoria, particularly when administered rapidly or at higher doses, and this euphoric effect contributes to its abuse potential and risk of dependence. 1
Evidence from FDA Drug Labeling
The FDA explicitly recognizes euphoria as an adverse effect associated with diazepam abuse and misuse. The official drug label lists euphoria among the adverse reactions that occur with benzodiazepine abuse and/or misuse, alongside other effects like confusion, amnesia, and disinhibition 1. This is not merely a theoretical concern—the FDA categorizes diazepam as a Schedule IV controlled substance specifically because of its potential for abuse related to its desirable psychological effects 1.
Mechanism and Clinical Evidence
The euphoric effect of diazepam is dose-dependent and rate-dependent:
Rapid onset enhances euphoria: Research demonstrates that 10-20 mg of diazepam produces euphoria, with the effect being significantly more pronounced when the drug reaches peak plasma levels quickly 2, 3. A controlled study showed that subjects receiving a single 20 mg dose (fast onset) reported significantly higher euphoria scores compared to the same total dose given in divided increments over time (slow onset), despite achieving similar peak plasma levels 3.
Higher doses amplify the effect: In studies of patients with substance use history, diazepam at 20-40 mg doses produced measurable euphoria that exceeded placebo, with the 40 mg dose rating highest among benzodiazepines tested 4, 5. Some patients taking 70-300 mg daily specifically sought this euphoric "boost" effect 2.
High-dose effects: At very high doses (150-200 mg/day), diazepam produces marked euphoria alongside analgesic effects, with studies showing partial reversal by the opioid antagonist naloxone, suggesting complex neurochemical mechanisms 6.
Clinical Implications and Risk Factors
Patients at highest risk for experiencing and seeking diazepam-induced euphoria include:
- Those with history of substance use disorders (particularly opioid or alcohol dependence)
- Individuals taking higher-than-prescribed doses
- Patients using diazepam in combination with opioids or alcohol (which potentiates euphoric effects but dangerously increases respiratory depression risk) 7
- Recreational users who specifically select diazepam for its rapid onset and pronounced sedative effects 2
Important Caveats
The euphoric effect is not universal—it varies significantly based on:
- Individual patient factors: Psychiatric comorbidities, prior substance exposure, and genetic variations in drug metabolism
- Route and timing: Oral administration produces less intense euphoria than intravenous use; divided dosing reduces euphoric peaks 3
- Clinical context: Patients receiving diazepam for legitimate anxiety or alcohol withdrawal may experience relief rather than euphoria
Critical warning: The pursuit of euphoria drives misuse patterns that lead to tolerance, physical dependence, and potentially life-threatening withdrawal reactions including seizures 1. When combined with other CNS depressants, the risk of fatal overdose increases substantially due to synergistic respiratory depression 7.
Prescribing Considerations
Given this abuse potential, prescribers should:
- Limit diazepam to short-term use for appropriate indications
- Screen for substance use history before prescribing
- Monitor for signs of dose escalation or early refill requests
- Consider alternative benzodiazepines with slower onset (like oxazepam) or non-benzodiazepine options when abuse risk is elevated
- Educate patients that euphoria signals potential for dependence, not therapeutic benefit 7
The evidence unequivocally establishes that diazepam's euphoric properties are real, clinically significant, and central to its classification as a controlled substance with abuse potential.